AI assistant
BALCHEM CORP — Director's Dealing 2024
Aug 2, 2024
31041_dirs_2024-08-01_0af0786d-3286-4c0b-8d2c-8d33711cb32e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2024-07-30
Reporting Person: Backus William A. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-07-30 | Common Stock | M | 3900 | $84.09 | Acquired | 8888 | Direct |
| 2024-07-30 | Common Stock | S | 3570 | $179.247 | Disposed | 5318 | Direct |
| 2024-07-30 | Common Stock | S | 330 | $180.4656 | Disposed | 4988 | Direct |
| 2024-07-30 | Common Stock | S | 904 | $177.0955 | Disposed | 132 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-07-30 | Stock Options (right to buy) | $84.09 | M | 3900 | Disposed | 2029-02-13 | Common Stock (3900) | Direct |
Footnotes
F1: Exercise of fully vested non-qualified stock options.
F2: This transaction was executed in multiple sales ranging from $179.0200 to $179.9700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F3: This transaction was executed in multiple sales ranging from $180.3050 to $180.5900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F4: Intra-plan transfer from the Balchem Common Stock Fund to another fund within the Balchem Corporation 401(k) plan.
F5: Reflects shares previously acquired under the Balchem Corporation 401(k) plan.
F6: Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.